Global Hormone Refractory Prostate Cancer Market Growth (Status and Outlook) 2024-2030

September 2024 | 79 pages | ID: G3C9EDF680CEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Hormone Refractory Prostate Cancer market size was valued at US$ million in 2023. With growing demand in downstream market, the Hormone Refractory Prostate Cancer is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Hormone Refractory Prostate Cancer market. Hormone Refractory Prostate Cancer are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hormone Refractory Prostate Cancer. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hormone Refractory Prostate Cancer market.

Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.

Key Features:

The report on Hormone Refractory Prostate Cancer market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Hormone Refractory Prostate Cancer market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Hormonal Therapy), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hormone Refractory Prostate Cancer market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Hormone Refractory Prostate Cancer market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Hormone Refractory Prostate Cancer industry. This include advancements in Hormone Refractory Prostate Cancer technology, Hormone Refractory Prostate Cancer new entrants, Hormone Refractory Prostate Cancer new investment, and other innovations that are shaping the future of Hormone Refractory Prostate Cancer.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hormone Refractory Prostate Cancer market. It includes factors influencing customer ' purchasing decisions, preferences for Hormone Refractory Prostate Cancer product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hormone Refractory Prostate Cancer market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hormone Refractory Prostate Cancer market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hormone Refractory Prostate Cancer market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hormone Refractory Prostate Cancer industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hormone Refractory Prostate Cancer market.

Market Segmentation:

Hormone Refractory Prostate Cancer market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Chemotherapy
• Hormonal Therapy
• Immunotherapy
• Radiation Therapy

Segmentation by application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astellas Inc
• Sanofi S.A
• Dendreon Corporation, Bayer AG
• Johnson & Johnson

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hormone Refractory Prostate Cancer Market Size 2019-2030
  2.1.2 Hormone Refractory Prostate Cancer Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hormone Refractory Prostate Cancer Segment by Type
  2.2.1 Chemotherapy
  2.2.2 Hormonal Therapy
  2.2.3 Immunotherapy
  2.2.4 Radiation Therapy
2.3 Hormone Refractory Prostate Cancer Market Size by Type
  2.3.1 Hormone Refractory Prostate Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
2.4 Hormone Refractory Prostate Cancer Segment by Application
  2.4.1 Hospitals
  2.4.2 Ambulatory Surgical Centers
  2.4.3 Specialty Clinics
2.5 Hormone Refractory Prostate Cancer Market Size by Application
  2.5.1 Hormone Refractory Prostate Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)

3 HORMONE REFRACTORY PROSTATE CANCER MARKET SIZE BY PLAYER

3.1 Hormone Refractory Prostate Cancer Market Size Market Share by Players
  3.1.1 Global Hormone Refractory Prostate Cancer Revenue by Players (2019-2024)
  3.1.2 Global Hormone Refractory Prostate Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Hormone Refractory Prostate Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HORMONE REFRACTORY PROSTATE CANCER BY REGIONS

4.1 Hormone Refractory Prostate Cancer Market Size by Regions (2019-2024)
4.2 Americas Hormone Refractory Prostate Cancer Market Size Growth (2019-2024)
4.3 APAC Hormone Refractory Prostate Cancer Market Size Growth (2019-2024)
4.4 Europe Hormone Refractory Prostate Cancer Market Size Growth (2019-2024)
4.5 Middle East & Africa Hormone Refractory Prostate Cancer Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Hormone Refractory Prostate Cancer Market Size by Country (2019-2024)
5.2 Americas Hormone Refractory Prostate Cancer Market Size by Type (2019-2024)
5.3 Americas Hormone Refractory Prostate Cancer Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hormone Refractory Prostate Cancer Market Size by Region (2019-2024)
6.2 APAC Hormone Refractory Prostate Cancer Market Size by Type (2019-2024)
6.3 APAC Hormone Refractory Prostate Cancer Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hormone Refractory Prostate Cancer by Country (2019-2024)
7.2 Europe Hormone Refractory Prostate Cancer Market Size by Type (2019-2024)
7.3 Europe Hormone Refractory Prostate Cancer Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hormone Refractory Prostate Cancer by Region (2019-2024)
8.2 Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Type (2019-2024)
8.3 Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HORMONE REFRACTORY PROSTATE CANCER MARKET FORECAST

10.1 Global Hormone Refractory Prostate Cancer Forecast by Regions (2025-2030)
  10.1.1 Global Hormone Refractory Prostate Cancer Forecast by Regions (2025-2030)
  10.1.2 Americas Hormone Refractory Prostate Cancer Forecast
  10.1.3 APAC Hormone Refractory Prostate Cancer Forecast
  10.1.4 Europe Hormone Refractory Prostate Cancer Forecast
  10.1.5 Middle East & Africa Hormone Refractory Prostate Cancer Forecast
10.2 Americas Hormone Refractory Prostate Cancer Forecast by Country (2025-2030)
  10.2.1 United States Hormone Refractory Prostate Cancer Market Forecast
  10.2.2 Canada Hormone Refractory Prostate Cancer Market Forecast
  10.2.3 Mexico Hormone Refractory Prostate Cancer Market Forecast
  10.2.4 Brazil Hormone Refractory Prostate Cancer Market Forecast
10.3 APAC Hormone Refractory Prostate Cancer Forecast by Region (2025-2030)
  10.3.1 China Hormone Refractory Prostate Cancer Market Forecast
  10.3.2 Japan Hormone Refractory Prostate Cancer Market Forecast
  10.3.3 Korea Hormone Refractory Prostate Cancer Market Forecast
  10.3.4 Southeast Asia Hormone Refractory Prostate Cancer Market Forecast
  10.3.5 India Hormone Refractory Prostate Cancer Market Forecast
  10.3.6 Australia Hormone Refractory Prostate Cancer Market Forecast
10.4 Europe Hormone Refractory Prostate Cancer Forecast by Country (2025-2030)
  10.4.1 Germany Hormone Refractory Prostate Cancer Market Forecast
  10.4.2 France Hormone Refractory Prostate Cancer Market Forecast
  10.4.3 UK Hormone Refractory Prostate Cancer Market Forecast
  10.4.4 Italy Hormone Refractory Prostate Cancer Market Forecast
  10.4.5 Russia Hormone Refractory Prostate Cancer Market Forecast
10.5 Middle East & Africa Hormone Refractory Prostate Cancer Forecast by Region (2025-2030)
  10.5.1 Egypt Hormone Refractory Prostate Cancer Market Forecast
  10.5.2 South Africa Hormone Refractory Prostate Cancer Market Forecast
  10.5.3 Israel Hormone Refractory Prostate Cancer Market Forecast
  10.5.4 Turkey Hormone Refractory Prostate Cancer Market Forecast
  10.5.5 GCC Countries Hormone Refractory Prostate Cancer Market Forecast
10.6 Global Hormone Refractory Prostate Cancer Forecast by Type (2025-2030)
10.7 Global Hormone Refractory Prostate Cancer Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Astellas Inc
  11.1.1 Astellas Inc Company Information
  11.1.2 Astellas Inc Hormone Refractory Prostate Cancer Product Offered
  11.1.3 Astellas Inc Hormone Refractory Prostate Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Astellas Inc Main Business Overview
  11.1.5 Astellas Inc Latest Developments
11.2 Sanofi S.A
  11.2.1 Sanofi S.A Company Information
  11.2.2 Sanofi S.A Hormone Refractory Prostate Cancer Product Offered
  11.2.3 Sanofi S.A Hormone Refractory Prostate Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Sanofi S.A Main Business Overview
  11.2.5 Sanofi S.A Latest Developments
11.3 Dendreon Corporation, Bayer AG
  11.3.1 Dendreon Corporation, Bayer AG Company Information
  11.3.2 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product Offered
  11.3.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Dendreon Corporation, Bayer AG Main Business Overview
  11.3.5 Dendreon Corporation, Bayer AG Latest Developments
11.4 Johnson & Johnson
  11.4.1 Johnson & Johnson Company Information
  11.4.2 Johnson & Johnson Hormone Refractory Prostate Cancer Product Offered
  11.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Johnson & Johnson Main Business Overview
  11.4.5 Johnson & Johnson Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hormone Refractory Prostate Cancer Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Hormonal Therapy
Table 4. Major Players of Immunotherapy
Table 5. Major Players of Radiation Therapy
Table 6. Hormone Refractory Prostate Cancer Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Hormone Refractory Prostate Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Table 9. Hormone Refractory Prostate Cancer Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Hormone Refractory Prostate Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Table 12. Global Hormone Refractory Prostate Cancer Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Hormone Refractory Prostate Cancer Revenue Market Share by Player (2019-2024)
Table 14. Hormone Refractory Prostate Cancer Key Players Head office and Products Offered
Table 15. Hormone Refractory Prostate Cancer Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Hormone Refractory Prostate Cancer Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Hormone Refractory Prostate Cancer Market Size Market Share by Regions (2019-2024)
Table 20. Global Hormone Refractory Prostate Cancer Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Hormone Refractory Prostate Cancer Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Hormone Refractory Prostate Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Country (2019-2024)
Table 24. Americas Hormone Refractory Prostate Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Table 26. Americas Hormone Refractory Prostate Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Table 28. APAC Hormone Refractory Prostate Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Region (2019-2024)
Table 30. APAC Hormone Refractory Prostate Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Table 32. APAC Hormone Refractory Prostate Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Table 34. Europe Hormone Refractory Prostate Cancer Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Country (2019-2024)
Table 36. Europe Hormone Refractory Prostate Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Table 38. Europe Hormone Refractory Prostate Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Hormone Refractory Prostate Cancer
Table 47. Key Market Challenges & Risks of Hormone Refractory Prostate Cancer
Table 48. Key Industry Trends of Hormone Refractory Prostate Cancer
Table 49. Global Hormone Refractory Prostate Cancer Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Hormone Refractory Prostate Cancer Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Hormone Refractory Prostate Cancer Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Astellas Inc Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors
Table 54. Astellas Inc Hormone Refractory Prostate Cancer Product Offered
Table 55. Astellas Inc Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Astellas Inc Main Business
Table 57. Astellas Inc Latest Developments
Table 58. Sanofi S.A Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors
Table 59. Sanofi S.A Hormone Refractory Prostate Cancer Product Offered
Table 60. Sanofi S.A Main Business
Table 61. Sanofi S.A Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Sanofi S.A Latest Developments
Table 63. Dendreon Corporation, Bayer AG Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors
Table 64. Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product Offered
Table 65. Dendreon Corporation, Bayer AG Main Business
Table 66. Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Dendreon Corporation, Bayer AG Latest Developments
Table 68. Johnson & Johnson Details, Company Type, Hormone Refractory Prostate Cancer Area Served and Its Competitors
Table 69. Johnson & Johnson Hormone Refractory Prostate Cancer Product Offered
Table 70. Johnson & Johnson Main Business
Table 71. Johnson & Johnson Hormone Refractory Prostate Cancer Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Johnson & Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hormone Refractory Prostate Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hormone Refractory Prostate Cancer Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hormone Refractory Prostate Cancer Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hormone Refractory Prostate Cancer Sales Market Share by Country/Region (2023)
Figure 8. Hormone Refractory Prostate Cancer Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2023
Figure 10. Hormone Refractory Prostate Cancer in Hospitals
Figure 11. Global Hormone Refractory Prostate Cancer Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Hormone Refractory Prostate Cancer in Ambulatory Surgical Centers
Figure 13. Global Hormone Refractory Prostate Cancer Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. Hormone Refractory Prostate Cancer in Specialty Clinics
Figure 15. Global Hormone Refractory Prostate Cancer Market: Specialty Clinics (2019-2024) & ($ Millions)
Figure 16. Global Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2023
Figure 17. Global Hormone Refractory Prostate Cancer Revenue Market Share by Player in 2023
Figure 18. Global Hormone Refractory Prostate Cancer Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Hormone Refractory Prostate Cancer Market Size 2019-2024 ($ Millions)
Figure 20. APAC Hormone Refractory Prostate Cancer Market Size 2019-2024 ($ Millions)
Figure 21. Europe Hormone Refractory Prostate Cancer Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Hormone Refractory Prostate Cancer Market Size 2019-2024 ($ Millions)
Figure 23. Americas Hormone Refractory Prostate Cancer Value Market Share by Country in 2023
Figure 24. United States Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Region in 2023
Figure 29. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Type in 2023
Figure 30. APAC Hormone Refractory Prostate Cancer Market Size Market Share by Application in 2023
Figure 31. China Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Country in 2023
Figure 38. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Figure 39. Europe Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Figure 40. Germany Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Hormone Refractory Prostate Cancer Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Hormone Refractory Prostate Cancer Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 54. APAC Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 55. Europe Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 57. United States Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 58. Canada Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 61. China Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 62. Japan Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 63. Korea Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 65. India Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 66. Australia Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 67. Germany Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 68. France Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 69. UK Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 70. Italy Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 71. Russia Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 72. Spain Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 75. Israel Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Hormone Refractory Prostate Cancer Market Size 2025-2030 ($ Millions)
Figure 78. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Hormone Refractory Prostate Cancer Market Size Market Share Forecast by Application (2025-2030)